Abstract:Introduction: One major obstacle in validating drugs for the treatment or prevention of hearing loss is the limited data available on the distribution and concentration of drugs in the human inner ear. Although small animal models offer some insights into inner ear pharmacokinetics, their smaller organ size and different barrier (round window membrane) permeabilities compared to humans can complicate study interpretation. Therefore, developing a reliable large animal model for inner ear drug delivery is crucial. The inner and middle ear anatomy of domestic pigs closely resembles that of humans, making them promising candidates for studying inner ear pharmacokinetics. However, unlike humans, the anatomical orientation and tortuosity of the porcine external ear canal frustrates local drug delivery to the inner ear. Methods: In this study, we developed a surgical technique to access the tympanic membrane of pigs. To assess hearing pre- and post-surgery, auditory brainstem responses to click and pure tones were measured. Additionally, we performed 3D segmentation of the porcine inner ear images and used this data to simulate the diffusion of dexamethasone within the inner ear through fluid simulation software (FluidSim). Results: We have successfully delivered dexamethasone and dexamethasone sodium phosphate to the porcine inner ear via the intratympanic injection. The recorded auditory brainstem measurements revealed no adverse effects on hearing thresholds attributable to the surgery. We have also simulated the diffusion rates for dexamethasone and dexamethasone sodium phosphate into the porcine inner ear and confirmed the accuracy of the simulations using in-vivo data. Discussion: We have developed and characterized a method for conducting pharmacokinetic studies of the inner ear using pigs. This animal model closely mirrors the size of the human cochlea and the thickness of its barriers. The diffusion time and drug concentrations we reported align closely with the limited data available from human studies. Therefore, we have demonstrated the potential of using pigs as a large animal model for studying inner ear pharmacokinetics.

Improved intracochlear biopolymeric drug delivery system: an in vivo study

Local Delivery of Therapeutics to the Cochlea Using Nanoparticles and Other Biomaterials

Treating Sensorineural Hearing Loss: Recent Advances in Inner Ear Drug Delivery

Inner Ear Drug Delivery for Sensorineural Hearing Loss: Current Challenges and Opportunities

Cutting‐Edge Achievements of Inner Ear Drug Delivery Systems

Exploring delivery systems for targeted nanotechnology-based gene therapy in the inner ear

Enhancement of Bioavailability and Bioequivalence of Drug Delivery in Sensory Neural Hearing Loss

Development of Novel Drug Carrier Via Round Window Membrane

The Progress of Topical Drug Delivery to the Inner Ear for the Inhibition of Inflammation and Fibrosis Following Cochlear Implantation

Drug delivery systems for the treatment of sensorineural hearing loss

Biomaterials for non-invasive trans-tympanic drug delivery: requirements, recent advances and perspectives

Drug Delivery Across Barriers to the Middle and Inner Ear.

High-Precision 3D Printing of Microporous Cochlear Implants for Personalized Local Drug Delivery

Nanoparticle-based inner ear delivery systems for the treatment of hearing loss

Application of Nanomedicine in Inner Ear Diseases

Semicircular canal drug delivery safely targets the inner ear perilymphatic space

Development of a drug delivering round window niche implant for cochlear pharmacotherapy

Insertion trauma of a novel inner ear catheter for intracochlear drug delivery

A prestin-targeting peptide-guided drug delivery system rearranging concentration gradient in the inner ear: an improved strategy against hearing loss

Recent Advances and Future Research Directions for Hearing Loss Treatment Based on Nanoparticles

Surgical procedure of intratympanic injection and inner ear pharmacokinetics simulation in domestic pigs